| 1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
| 2 |
Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research[J]. Lancet Infect Dis, 2015, 15 (5): 581-614.
|
| 3 |
Fleischmann C, Scherag A, Adhikari NK, et al. Asses-sment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016, 193 (3): 259-272.
|
| 4 |
Martin GS. Sepsis, severe sepsis and septic shock: ch-anges in incidence, pathogens and outcomes[J]. Expert Rev Anti Infect Ther, 2012, 10 (6): 701-706.
|
| 5 |
Goodwin AJ, Rice DA, Simpson KN, et al. Frequency, cost, and risk factors of readmissions among severe sepsis survivors[J]. Crit Care Med, 2015, 43 (4): 738-746.
|
| 6 |
Yende S, Austin S, Rhodes A, et al. Long-term quality of life among survivors of severe sepsis: analyses of two international trials[J]. Crit Care Med, 2016, 44 (8): 1461-1467.
|
| 7 |
Annane D, Sharshar T. Cognitive decline after sepsis[J]. Lancet Respir Med, 2015, 3 (1): 61-69.
|
| 8 |
Prescott HC, Langa KM, Liu V, et al. Increased l-year healthcare use in survivors of severe sepsis[J]. Am J Respir Crit Care Med, 2014, 190 (1): 62-69.
|
| 9 |
Citro A, Barnaba V, Martini H. From T cell apoptosis to chronic immune activation in inflammatory diseases[J]. Int Arch Allergy Immunol, 2014, 164 (2): 140-146.
|
| 10 |
Pauken KE, Wherry EJ. SnapShot: T cell exhaustion[J]. Cell, 2015, 163 (4): 1038-1038.e1.
|
| 11 |
Liu Q, An L, Qi Z, et al. Increased expression of programmed cell death-1 in regulatory T cells of patients with severe sepsis and septic shock: an observational clinical study[J]. Scand J Immunol, 2017, 86 (5): 408-417.
|
| 12 |
Gao DN, Yang ZX, Qi QH. Roles of PD-1, Tim-3 and CTLA-4 in immunoregulation in regulatory T cells among patients with sepsis[J]. Int J Clin Exp Med, 2015, 8 (10): 18998-19005.
|
| 13 |
Lange A, Sundén-Cullberg J, Magnuson A, et al. Solu-ble B and T lymphocyte attenuator correlates to disease severity in sepsis and high levels are associated with an increased risk of mortality[J]. PLoS One, 2017, 12 (1): e0169176.
|
| 14 |
Jayaraman P, Jacques MK, Zhu C, et al. TIM3 mediates T cell exhaustion during Mycobacterium tuberculosis infection[J]. PLoS Pathog, 2016, 12 (3): e1005490.
|
| 15 |
Liu Q, Li CS. Programmed cell death-1/programmed death-ligand 1 pathway: a new target for sepsis[J]. Chin Med J (Engl), 2017, 130 (8): 986-992.
|
| 16 |
Lukewich MK, Rogers RC, Lomax AE. Divergent neuroendocrine responses to localised and systemic inflammation[J]. Semin Immunol, 2014, 26 (5): 402-408.
|
| 17 |
Kanczkowski W, Sue M, Bornstein SR. Adrenal gland microenvironment and its involvement in the regulation of stress-induced hormone secretion during sepsis[J]. Front Endocrinol (Lausanne), 2016 (7): 156.
|
| 18 |
Wu CL, Wu QY, Du JJ, et al. Calcium-sensing receptor in the T lymphocyte enhanced the apoptosis and cytokine secretion in sepsis[J]. Mol Immunol, 2015, 63 (2): 337-342.
|
| 19 |
Andreu-Ballester JC, Cuellar C, Garcia-Ballesteros C, et al. Deficit of interleukin 7 in septic patients[J]. Int Immunopharmacol, 2014, 23 (1): 73-76.
|
| 20 |
潘东峰，李富荣，梁诗颂，等. 淋巴细胞亚群联合检测对脓毒症患者不良预后的评估价值[J]. 中华急诊医学杂志，2015，24(5): 524-529.
|
| 21 |
Luckheeram RV, Zhou R, Verma AD, et al. CD4+T cells: differentiation and functions[J]. Clin Dev Immunol, 2012 (2012): 925135.
|
| 22 |
Zhu J, Paul WE. CD4 T cells: fates, functions, and faults[J]. Blood, 2008, 112 (5): 1557-1569.
|
| 23 |
Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure[J]. JAMA, 2011, 306 (23): 2594-2605.
|
| 24 |
Gupta DL, Bhoi S, Mohan T, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis[J]. Cytokine, 2016 (88): 214-221.
|
| 25 |
Wu HP, Lin YK. Effect of Eucommia ulmoides Oliv., Gynostemma pentaphyllum (Thunb.) Makino, and Curcuma longa L. on Th1- and Th2-cytokine responses and human leukocyte antigen-DR expression in peripheral blood mononuclear cells of septic patients[J]. J Ethnopharmacol, 2018 (217): 195-204.
|
| 26 |
Wu HP, Chung K, Lin CY, et al. Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality ín severe sepsis[J]. Inflamm Res, 2013, 62 (8): 751-763.
|
| 27 |
Yao YM, Huang LF. The potential role of regulatory T cells in postburn sepsis[J]. Zhonghua Shao Shang Za Zhi, 2011, 27 (2): 81-83.
|
| 28 |
Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis[J]. Crit Care Med, 2003, 31 (7): 2068-2071.
|
| 29 |
万健，单怡，张冬青，等. 脓毒症小鼠CD4+CD25+Foxp3+T细胞变化及其意义[J/CD]. 中华临床医师杂志（电子版），2012，6(15): 4353-4357.
|
| 30 |
耿延青. 脓毒症患者血中CD4+CD25+调节性T细胞水平与机体细胞免疫状态的相关性研究[J]. 中国医药导报，2015，12(3): 7-10，23.
|
| 31 |
Chen K, Zhou QX, Shan HW, et al. Prognostic value of CD4+CD25+ Tregs as a valuable biomarker for patients with sepsis in ICU[J]. World J Emerg Med, 2015, 6 (1): 40-43.
|
| 32 |
Duong S, Condotta SA, Rai D, et al. Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions[J]. J Immunol, 2014, 192 (8): 3618-3625.
|
| 33 |
孟小征，马怀安，乔博明，等. T淋巴细胞、炎性因子及心肌酶对脓毒症严重程度的评估价值研究[J]. 临床误诊误治，2019，32(1): 75-79.
|
| 34 |
黄鑫波，明静. 脓毒症患者细胞免疫状态与预后的研究[J]. 医药前沿，2019，9(17): 131.
|
| 35 |
胡彩珍，叶立刚，徐善祥. T细胞亚群监测在基于Sepsis-3的创伤性脓毒症患者中的应用[J]. 中华急诊医学杂志，2019，28(2): 181-184.
|
| 36 |
曲冰杰，郭剑颖，王宏伟. 脓毒症患者免疫紊乱中树突细胞与T细胞分化及表型研究[J]. 中国免疫学杂志，2019，35(12): 1487-1490.
|
| 37 |
Francois B, Jeannet R, Daix T, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial[J]. JCI Insight, 2018, 3 (5): e98960.
|
| 38 |
Pei F, Guan X, Wu J. Thymosin alpha 1 treatment for patients with sepsis[J]. Expert Opin Biol Ther, 2018, 18 (sup1): 71-76.
|
| 39 |
卢铭，李佳峻. 乌司他丁联合胸腺肽α1对脓毒症患者外周血T淋巴细胞亚群及炎症因子水平影响[J]. 创伤与急危重病医学，2018，6(6): 369-371，374.
|
| 40 |
Wakeley ME, Gray CC, Monaghan SF, et al. Check point inhibitors and their role in immunosuppression in sepsis[J]. Crit Care Clin, 2020, 36 (1): 69-88.
|
| 41 |
陈宇，冯芳，陈伟，等. 脓毒症患者应用代谢复苏疗法28例分析[J/CD]. 中华危重症医学杂志（电子版），2019，12(5): 343-346.
|